GGrantScoutHQCreate alert

Curated topic

Technology Grants for Small Businesses — Page 7

Current technology, digital adoption and innovation opportunities that list small businesses as eligible applicants.

263 current opportunities · showing 145–168

OPENResearch & Science

NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)

National Institutes of Health

This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this

Deadline
Oct 13, 2027
Funding
Estimated total program funding: $500,000
Check fit and official source →
OPENHealth & Medical

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

National Institutes of Health

The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas wit

Deadline
Oct 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this funding opportunity announcement (FOA) is to fund meritorious vision-related research projects that involve secondary data analyses using existing database resources. The development of statistical methodology necessary for improving methods to analyze vision health data using exist

Deadline
Oct 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) solicits applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagn

Deadline
Oct 20, 2027
Funding
Estimated total program funding: $2,400,000
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a si

Deadline
Oct 21, 2027
Funding
Estimated total program funding: $750,000
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall und

Deadline
Oct 21, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of I

Deadline
Oct 21, 2027
Funding
Estimated total program funding: $750,000
Check fit and official source →
OPENHealth & Medical

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

National Institutes of Health

Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (A

Deadline
Oct 26, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

National Institutes of Health

Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders

Deadline
Oct 26, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were

Deadline
Nov 6, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

National Institutes of Health

The Theories, Models and Methods (TMM) initiative will support the development of computational tools for understanding dynamic brain circuits that are made broadly accessible to the greater research community. This program supports applications focused on tool building and dissemination in the doma

Deadline
Nov 9, 2027
Funding
See official notice
Check fit and official source →
OPENDisability & Accessibility

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observ

Deadline
Nov 16, 2027
Funding
Up to $6,250,000
Check fit and official source →
OPENHealth & Medical

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics

Deadline
Nov 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biolo

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENResearch & Science

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of Health

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support

Deadline
Nov 19, 2027
Funding
Estimated total program funding: $300,000
Check fit and official source →
OPENHealth & Medical

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this Notice of Opportunity Announcement (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescri

Deadline
Dec 4, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription

Deadline
Dec 4, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

National Institutes of Health

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in

Deadline
Dec 24, 2027
Funding
Up to $350,000
Check fit and official source →
OPENResearch & Science

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

National Institutes of Health

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

National Institutes of Health

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvem

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENResearch & Science

NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)

National Institutes of Health

The NIH Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained resear

Deadline
Jan 8, 2028
Funding
Up to $50,000
Check fit and official source →
OPENResearch & Science

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) supports projects relevant to the NIGMS mission that focus solely on the development of technologies with potential to enable acquisition of biomedical knowledge. Projects should be justified in terms of technical innovation and utility of such technical inn

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)

National Institutes of Health

NIMH seeks applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness, and quality of digital mental health interventions. This NOFO is intended to support the development of digital health test beds that leverage well-established digital mental

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →
OPENResearch & Science

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

National Institutes of Health

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel

Deadline
Jan 8, 2028
Funding
See official notice
Check fit and official source →

Strong fit signals

  • A project milestone is specific and measurable
  • The business meets size and ownership rules
  • Eligible costs match the planned work

Requirements to verify

  • R&D versus commercialization restrictions
  • Cost-share and intellectual-property terms

How to use this shortlist

Open the official notice for each candidate and build a simple go/no-go table covering legal applicant type, geography, project purpose, award range, match, registrations and submission time zone. Eliminate any program that fails a mandatory condition before spending time on narrative drafting.

Frequently asked questions

Who should use this technology grants for small businesses page?

Small businesses planning a defined technology or innovation project. Treat the directory match as a discovery signal and confirm the controlling eligibility language on the funder's notice.

How are opportunities selected?

The page applies a fixed combination of structured applicant, focus, source, award or deadline signals to current directory records. It does not broaden the result with unrelated keywords.

Does a listing mean my organization is eligible?

No. A match helps build a shortlist; the official notice, application package and funder guidance control eligibility and allowable costs.